Thyrocare Technologies Limited reports revenue of INR 240.02 Cr in Q1FY27 with a growth of 24% YoY
NiveshIQ
NSE: THYROCARE · IT
Thyrocare Technologies Ltd.
₹580.00▲ ₹0.30 (+0.05%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on THYROCARE. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Thyrocare Technologies Ltd.
Thyrocare Technologies Limited is a leading diagnostic testing services provider in India, operating through three segments: Diagnostic Testing Services, Imaging Services, and Others. The company offers a range of diagnostic and pathological services, including the sale of consumables, radio-pharmaceuticals, and glucometers. Its Diagnostic Testing Services segment is a key revenue driver, accounting for a significant portion of the company's revenue. In recent quarters, Thyrocare has posted strong financial results, with a 24% increase in revenue and a 34% surge in net profit in Q1 FY27. The company has also expanded its presence in the specialty diagnostics market, further solidifying its position in the Indian healthcare sector. With a strong track record of growth and a growing market s
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹572.00 Cr +116.70% | ₹687.00 Cr +20.10% | ₹829.95 Cr +20.80% |
| EBITDA Margin | 24.30% | 27.51% | 32.10% |
| Net Profit | ₹69.00 Cr +155.60% | ₹91.00 Cr +31.90% | ₹162.70 Cr +78.80% |
| EPS | ₹4.46 | ₹5.76 | ₹10.28 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Thyrocare Technologies Limited reports revenue of INR 240.02 Cr in Q1FY27 with a growth of 24% YoY
Thyrocare Posts Strong Q1 FY27 Results with ₹240 Crore Revenue and 24.3% YoY Growth
🔒
+ 3 more stories about Thyrocare Technologies Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹240 Cr, PAT ₹51 Cr, EPS ₹3.23, EBITDA margin 33.9%. Growth context: revenue QoQ +7.2%, PAT QoQ +5.4%. Street verdict: miss, revenue surprise +5.2%, PAT surprise -43.6%.
Test volumes, test mix, B2B/reference-lab traction, pricing discipline, and operating leverage are the key drivers for T...
FY26 (last completed FY): revenue ₹830 Cr, PAT ₹163 Cr, EBITDA margin 32.1%, EPS ₹10.28. Year-on-year: revenue YoY +20.8...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for THYROCARE
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track THYROCARE alongside your other holdings
Unlock full THYROCARE research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Thyrocare Technologies Ltd.?
NiveshIQ detects active intelligence signals for Thyrocare Technologies Ltd. (THYROCARE) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Thyrocare Technologies Ltd.?
Thyrocare Technologies Ltd. operates in the IT sector with a market capitalisation of ₹773,525.8L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.